SIMPLEX TRADING, LLC - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 132 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2016. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q1 2023$2,293
+601.2%
42,348
+584.2%
0.00%
Q4 2022$327
-99.9%
6,189
-45.9%
0.00%
-100.0%
Q3 2022$531,000
+172.3%
11,431
+98.5%
0.00%
Q1 2021$195,000
-77.1%
5,758
-78.5%
0.00%
-100.0%
Q4 2020$853,000
+10.1%
26,839
-11.1%
0.00%0.0%
Q3 2020$775,000
-37.9%
30,207
-37.9%
0.00%
-50.0%
Q2 2020$1,248,000
+109.4%
48,634
+25.3%
0.00%
+100.0%
Q1 2020$596,000
-53.7%
38,825
+3.4%
0.00%
-66.7%
Q4 2019$1,288,000
+186.9%
37,557
-37.6%
0.00%
+200.0%
Q3 2019$449,000
-36.8%
60,211
+84.0%
0.00%
-50.0%
Q3 2018$710,000
+57.1%
32,722
+27.9%
0.00%0.0%
Q2 2018$452,000
-32.5%
25,587
-19.6%
0.00%
-93.1%
Q1 2018$670,000
+43.2%
31,842
-1.6%
0.03%
+45.0%
Q4 2017$468,000
-19.4%
32,367
-12.2%
0.02%
-16.7%
Q3 2017$581,000
+50.1%
36,852
+18.1%
0.02%
+41.2%
Q2 2017$387,000
+19250.0%
31,214
+20168.8%
0.02%
Q1 2017$2,000
-99.3%
154
-99.2%
0.00%
-100.0%
Q4 2016$278,000
-82.4%
18,475
-82.1%
0.02%
-84.1%
Q3 2016$1,576,000
+2990.2%
103,463
+5441.7%
0.11%
+2575.0%
Q1 2016$51,000
-79.2%
1,867
-69.6%
0.00%
-77.8%
Q3 2015$245,0006,1430.02%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q4 2016
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 175,000$9,115,75010.70%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 317,856$16,547,5835.57%
Deep Track Capital, LP 2,600,000$135,434,0005.23%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,369,849$71,355,4343.86%
SILVERARC CAPITAL MANAGEMENT, LLC 208,730$10,872,7463.30%
DCF Advisers, LLC 107,157$5,581,8083.04%
Bellevue Group AG 3,170,250$165,138,3232.66%
Vahanian & Associates Financial Planning Inc. 15,217$792,6542.55%
Iron Triangle Partners LP 330,549$17,218,2972.52%
TANG CAPITAL MANAGEMENT LLC 300,000$15,627,0002.20%
View complete list of INTRA CELLULAR THERAPIES INC shareholders